Literature DB >> 29743728

Spatially correlated phenotyping reveals K5-positive luminal progenitor cells and p63-K5/14-positive stem cell-like cells in human breast epithelium.

Werner Boecker1,2, Laura van Horn3, Göran Stenman4, Christine Stürken5, Udo Schumacher5, Thomas Loening6, Lukas Liesenfeld3, Eberhard Korsching7, Doreen Gläser8, Katharina Tiemann3, Igor Buchwalow9.   

Abstract

Understanding the mechanisms regulating human mammary epithelium requires knowledge of the cellular constituents of this tissue. Different and partially contradictory definitions and concepts describing the cellular hierarchy of mammary epithelium have been proposed, including our studies of keratins K5 and/or K14 as markers of progenitor cells. Furthermore, we and others have suggested that the p53 homolog p63 is a marker of human breast epithelial stem cells. In this investigation, we expand our previous studies by testing whether immunohistochemical staining with monospecific anti-keratin antibodies in combination with an antibody against the stem cell marker p63 might help refine the different morphologic phenotypes in normal breast epithelium. We used in situ multilabel staining for p63, different keratins, the myoepithelial marker smooth muscle actin (SMA), the estrogen receptor (ER), and Ki67 to dissect and quantify the cellular components of 16 normal pre- and postmenopausal human breast epithelial tissue samples at the single-cell level. Importantly, we confirm the existence of K5+ only cells and suggest that they, in contrast to the current view, are key luminal precursor cells from which K8/18+ progeny cells evolve. These cells are further modified by the expression of ER and Ki67. We have also identified a population of p63+K5+ cells that are only found in nipple ducts. Based on our findings, we propose a new concept of the cellular hierarchy of human breast epithelium, including K5 luminal lineage progenitors throughout the ductal-lobular axis and p63+K5+ progenitors confined to the nipple ducts.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29743728     DOI: 10.1038/s41374-018-0054-3

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  6 in total

Review 1.  Integrating single-cell RNA-sequencing and functional assays to decipher mammary cell states and lineage hierarchies.

Authors:  Joseph L Regan; Matthew J Smalley
Journal:  NPJ Breast Cancer       Date:  2020-07-29

Review 2.  High-risk lesions of the breast: concurrent diagnostic tools and management recommendations.

Authors:  Francesca Catanzariti; Daly Avendano; Giuseppe Cicero; Margarita Garza-Montemayor; Carmelo Sofia; Emmanuele Venanzi Rullo; Giorgio Ascenti; Katja Pinker-Domenig; Maria Adele Marino
Journal:  Insights Imaging       Date:  2021-05-26

3.  Cytokeratin 5 determines maturation of the mammary myoepithelium.

Authors:  Vivi Deckwirth; Eeva Kaisa Rajakylä; Sandhanakrishnan Cattavarayane; Anna Acheva; Niccole Schaible; Ramaswamy Krishnan; Juan José Valle-Delgado; Monika Österberg; Pia Björkenheim; Antti Sukura; Sari Tojkander
Journal:  iScience       Date:  2021-04-15

4.  Peroxidasin Enhances Basal Phenotype and Inhibits Branching Morphogenesis in Breast Epithelial Progenitor Cell Line D492.

Authors:  Anna Karen Sigurdardottir; Arna Steinunn Jonasdottir; Arni Asbjarnarson; Hildur Run Helgudottir; Thorarinn Gudjonsson; Gunnhildur Asta Traustadottir
Journal:  J Mammary Gland Biol Neoplasia       Date:  2021-12-28       Impact factor: 2.673

Review 5.  Integrating single-cell RNA-sequencing and functional assays to decipher mammary cell states and lineage hierarchies.

Authors:  Joseph L Regan; Matthew J Smalley
Journal:  NPJ Breast Cancer       Date:  2020-07-29

6.  Co-expression of transcription factor AP-2beta (TFAP2B) and GATA3 in human mammary epithelial cells with intense, apicobasal immunoreactivity for CK8/18.

Authors:  M Raap; L Gierendt; C Werlein; E Kuehnle; H H Kreipe; M Christgen
Journal:  J Mol Histol       Date:  2021-06-11       Impact factor: 2.611

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.